Search results
Results from the WOW.Com Content Network
A mid-April report by the Census Bureau estimated the decline of retail sales to -8,7% in March 2020, with clothing sales falling hard with a 50.5% sales drop. The New York Times found the data comparable to those of the months following the 2008 financial crisis, even though stores remained opened that time. [ 6 ]
The volume of retail sales fell by a record 18.1%, following the strong monthly fall of 5.2% in March 2020. [94] The proportion spent online soared to the highest on record in April 2020 at 30.7%, which compares with the 19.1% reported in April 2019. [94] All 60 Cath Kidston stores to close after collapse. [95]
Travel to Ghana from countries with over 200 positive COVID-19 cases was deterred by authorities, with such travelers being denied admission; however, this restriction did not apply to Ghanaian citizens or people with resident permits. [171] All of the country's borders were later closed from midnight of Sunday 22 March 2020.
The company's options could include "moving production and aspects of the supply chain to different parts of the world," including from China to other parts of Asia and possibly Mexico, the ...
The dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its COVID-19 vaccine.. In ...
Bath & Body Works has struggled with consumers and investors as the pandemic beauty boom faded. Its shares are down nearly 14% year to date, compared to the S&P 500's 27% gain.
Most of the world's glove supply comes from Malaysia; [61] [62] Large orders with trusted companies were typically made "years in advance". Malaysia-based Top Glove and its subsidiary TG Medical were accused of violations of workers' rights, leading U.S. Customs and Border Protection (CBP) to ban their products in July 2020. [61]
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...